Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

NCT05892718

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hematology-Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • Carolina BioOncology Huntersville, North Carolina, United States
  • Greenville Hospital System University Medical Center (ITOR) Greenville, South Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT03666000

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Recruiting

NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma

NCT07114367

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Catholic univ of Yeouido St Mary's Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

NCT06484985

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Hunan Cancer Hosptial Changsha, China
  • Fujian Cancer Hospital Fuzhou, China
  • Sun Yat-Sen University Cancer Center Guangzhou, China
View Trial Details
Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
  • Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
  • Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
  • START Mountain Region /ID# 267592 West Valley City, Utah, United States
View all 14 locations
View Trial Details
Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details

Related conditions